• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于量子点的治疗性胶束与抗 EGFR 纳米抗体偶联用于三阴性乳腺癌治疗。

Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy.

机构信息

Department of Materials Science and Engineering and Wisconsin Institute for Discovery, University of Wisconsin-Madison , 330 N. Orchard Street, Madison, Wisconsin 53715, United States.

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison , 1111 Highland Avenue, Madison, Wisconsin 53706, United States.

出版信息

ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30297-30305. doi: 10.1021/acsami.7b05654. Epub 2017 Aug 28.

DOI:10.1021/acsami.7b05654
PMID:28845963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918284/
Abstract

A quantum-dot (QD)-based micelle conjugated with an anti-epidermal growth factor receptor (EGFR) nanobody (Nb) and loaded with an anticancer drug, aminoflavone (AF), has been engineered for EGFR-overexpressing cancer theranostics. The near-infrared (NIR) fluorescence of the indium phosphate core/zinc sulfide shell QDs (InP/ZnS QDs) allowed for in vivo nanoparticle biodistribution studies. The anti-EGFR nanobody 7D12 conjugation improved the cellular uptake and cytotoxicity of the QD-based micelles in EGFR-overexpressing MDA-MB-468 triple-negative breast cancer (TNBC) cells. In comparison with the AF-encapsulated nontargeted (i.e., without Nb conjugation) micelles, the AF-encapsulated Nb-conjugated (i.e., targeted) micelles accumulated in tumors at higher concentrations, leading to more effective tumor regression in an orthotopic triple-negative breast cancer xenograft mouse model. Furthermore, there was no systemic toxicity observed with the treatments. Thus, this QD-based Nb-conjugated micelle may serve as an effective theranostic nanoplatform for EGFR-overexpressing cancers such as TNBCs.

摘要

一种基于量子点(QD)的胶束与一种抗表皮生长因子受体(EGFR)纳米抗体(Nb)偶联,并负载抗癌药物氨基黄酮(AF),已被设计用于 EGFR 过表达癌症的治疗诊断。近红外(NIR)荧光的磷化铟核/硫化锌壳 QD(InP/ZnS QD)允许进行体内纳米颗粒生物分布研究。抗 EGFR 纳米抗体 7D12 的偶联提高了 QD 基胶束在 EGFR 过表达 MDA-MB-468 三阴性乳腺癌(TNBC)细胞中的细胞摄取和细胞毒性。与包封 AF 的非靶向(即,无 Nb 偶联)胶束相比,包封 AF 的 Nb 偶联(即靶向)胶束在肿瘤中以更高的浓度积累,导致在原位三阴性乳腺癌异种移植小鼠模型中更有效的肿瘤消退。此外,治疗中没有观察到全身毒性。因此,这种基于 QD 的 Nb 偶联胶束可作为 EGFR 过表达癌症(如 TNBC)的有效治疗诊断纳米平台。

相似文献

1
Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy.基于量子点的治疗性胶束与抗 EGFR 纳米抗体偶联用于三阴性乳腺癌治疗。
ACS Appl Mater Interfaces. 2017 Sep 13;9(36):30297-30305. doi: 10.1021/acsami.7b05654. Epub 2017 Aug 28.
2
Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.负载氨基黄酮的表皮生长因子受体靶向单分子胶束纳米颗粒在三阴性乳腺癌中显示出抗癌作用。
Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27.
3
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.抗 EGF 受体适体引导的联合递送抗癌 siRNAs 和量子点用于三阴性乳腺癌的治疗诊断学。
Theranostics. 2019 Jan 25;9(3):837-852. doi: 10.7150/thno.30228. eCollection 2019.
4
Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.载量子点和紫杉醇的抗 EGFR 脂质胶束纳米粒用于肿瘤靶向治疗。
Nanoscale. 2018 Nov 7;10(41):19338-19350. doi: 10.1039/c8nr05099f. Epub 2018 Oct 11.
5
Panitumumab-DOTA-In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner-Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer.Panitumumab-DOTA-In:一种用于 SPECT/CT 成像的表皮生长因子受体靶向治疗药物,以及用于三阴性乳腺癌的迈特纳-俄歇电子放射性免疫治疗。
Mol Pharm. 2022 Oct 3;19(10):3652-3663. doi: 10.1021/acs.molpharmaceut.2c00457. Epub 2022 Aug 4.
6
Novel Lipid Nanocomplex Co-Carrying Bcl2 siRNA and Quantum Dots for EGF Receptor-Targeted Anti-Cancer Theranosis.新型载 Bcl2siRNA 和量子点的脂质纳米复合物用于表皮生长因子受体靶向的抗癌联合治疗。
Int J Mol Sci. 2024 Jun 6;25(11):6246. doi: 10.3390/ijms25116246.
7
Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.靶向三阴性乳腺癌的 EGFR 可增强紫杉醇和西妥昔单抗偶联纳米金刚石纳米复合材料的治疗效果。
Acta Biomater. 2019 Mar 1;86:395-405. doi: 10.1016/j.actbio.2019.01.025. Epub 2019 Jan 16.
8
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.西妥昔单抗偶联维生素 E TPGS 胶束用于多烯紫杉醇的靶向递药治疗三阴性乳腺癌
Biomaterials. 2013 Dec;34(38):10160-71. doi: 10.1016/j.biomaterials.2013.09.043. Epub 2013 Oct 3.
9
EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy.表皮生长因子受体靶向纳米体功能化载甲氧基多聚己内酯的聚合物胶束用于选择性光动力治疗。
Mol Pharm. 2020 Apr 6;17(4):1276-1292. doi: 10.1021/acs.molpharmaceut.9b01280. Epub 2020 Mar 13.
10
In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.体内和体外概念验证表明,西妥昔单抗偶联维生素 E TPGS 胶束增加了递送多西他赛治疗三阴性乳腺癌的疗效。
Biomaterials. 2015 Sep;63:58-69. doi: 10.1016/j.biomaterials.2015.06.005. Epub 2015 Jun 6.

引用本文的文献

1
The Application of Functional Nanomaterials-Based Electrochemical Biosensors in Detecting Cancer Biomarkers: A Review.基于功能纳米材料的电化学生物传感器在癌症生物标志物检测中的应用:综述
Molecules. 2025 Jun 23;30(13):2708. doi: 10.3390/molecules30132708.
2
Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines.靶向肿瘤微环境的纳米抗体及其作为纳米药物的制剂。
Mol Cancer. 2025 Mar 4;24(1):65. doi: 10.1186/s12943-025-02270-5.
3
Nanotherapy for Neural Retinal Regeneration.用于神经视网膜再生的纳米疗法。

本文引用的文献

1
Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.基于神经内分泌肿瘤靶向性上转换纳米粒子的胶束用于近红外控制的联合化疗和光动力疗法以及荧光成像
Adv Funct Mater. 2017 Feb 23;27(8). doi: 10.1002/adfm.201604671. Epub 2017 Jan 17.
2
Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars.限制蛋白冠:一种成功的策略,用于针对抗 HER2 纳米体功能化纳米星的体内主动靶向。
Biomaterials. 2017 Apr;123:15-23. doi: 10.1016/j.biomaterials.2017.01.007. Epub 2017 Jan 6.
3
Adv Sci (Weinh). 2025 Jun;12(24):e2409854. doi: 10.1002/advs.202409854. Epub 2025 Jan 14.
4
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials.靶向受体酪氨酸激酶/非受体酪氨酸激酶作为治疗三阴性乳腺癌的有前景的治疗策略:来自临床试验的证据
Mil Med Res. 2024 Dec 12;11(1):76. doi: 10.1186/s40779-024-00582-z.
5
Role of Radiology in the Diagnosis and Treatment of Breast Cancer in Women: A Comprehensive Review.放射学在女性乳腺癌诊断与治疗中的作用:综述
Cureus. 2024 Sep 24;16(9):e70097. doi: 10.7759/cureus.70097. eCollection 2024 Sep.
6
Plug-and-play nucleic acid-mediated multimerization of biparatopic nanobodies for molecular imaging.用于分子成像的双特异性纳米抗体的即插即用型核酸介导多聚化
Mol Ther Nucleic Acids. 2024 Aug 15;35(3):102305. doi: 10.1016/j.omtn.2024.102305. eCollection 2024 Sep 10.
7
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities-A State-of-the-Art Review.量子点在乳腺癌诊断与治疗方式中的适用性——最新综述
Nanomaterials (Basel). 2024 Aug 31;14(17):1424. doi: 10.3390/nano14171424.
8
The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date).纳米材料作为药物递送系统和抗癌剂在三阴性乳腺癌治疗中的应用:最新综述(2005年至今)
Discov Nano. 2024 Sep 3;19(1):138. doi: 10.1186/s11671-024-04089-3.
9
Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence.光活性化合物在癌症诊治中的应用:光活性化学到人工智能的最新趋势综述。
Molecules. 2024 Jul 3;29(13):3164. doi: 10.3390/molecules29133164.
10
Quantum Dot Research in Breast Cancer: Challenges and Prospects.乳腺癌中的量子点研究:挑战与前景
Materials (Basel). 2024 May 4;17(9):2152. doi: 10.3390/ma17092152.
Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
负载氨基黄酮的表皮生长因子受体靶向单分子胶束纳米颗粒在三阴性乳腺癌中显示出抗癌作用。
Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27.
4
KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy.负载新型组蛋白去乙酰化酶抑制剂泰国埃坡霉素-A的KE108共轭单分子胶束用于靶向神经内分泌癌治疗。
Biomaterials. 2016 Aug;97:22-33. doi: 10.1016/j.biomaterials.2016.04.029. Epub 2016 Apr 26.
5
Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy.用于靶向癌症治疗的小型表皮生长因子受体1(EGFR1)和人表皮生长因子受体2(HER2)特异性双功能抗体
Theranostics. 2015 Jan 21;5(4):378-98. doi: 10.7150/thno.10084. eCollection 2015.
6
Nanobody-based cancer therapy of solid tumors.基于纳米抗体的实体瘤癌症治疗
Nanomedicine (Lond). 2015 Jan;10(1):161-74. doi: 10.2217/nnm.14.178.
7
Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies.使用单域抗体在复杂生物条件下对表皮生长因子受体进行诊断性纳米颗粒靶向。
Nanoscale. 2014 Jun 7;6(11):6046-56. doi: 10.1039/c4nr00595c. Epub 2014 Apr 29.
8
Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging.基于刷状两亲性嵌段共聚物的诊疗单分子胶束用于肿瘤靶向给药和正电子发射断层扫描成像。
ACS Appl Mater Interfaces. 2014 Dec 24;6(24):21769-79. doi: 10.1021/am5002585. Epub 2014 Mar 14.
9
Recent progress in the development of near-infrared fluorescent probes for bioimaging applications.近红外荧光探针在生物成像应用中的最新进展。
Chem Soc Rev. 2014 Jan 7;43(1):16-29. doi: 10.1039/c3cs60271k. Epub 2013 Sep 19.
10
Targeting tumors with nanobodies for cancer imaging and therapy.利用纳米抗体靶向肿瘤进行癌症成像和治疗。
J Control Release. 2013 Dec 28;172(3):607-17. doi: 10.1016/j.jconrel.2013.08.298. Epub 2013 Sep 11.